UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...
A network of proteins and fibers known as an extracellular matrix (ECM) provides support and structure to tissues and cells throughout our bodies. The ECM also facilitates cell-to-cell communications ...
Headquartered in Westworks, White City Place, London, UK. Investors include Netherton Investments (a fund investing on behalf of Mike Platt) and Dompé farmaceutici S.P.A. For more information, visit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback